ANAPTYSBIO, INC Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Anaptysbio, Inc quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q3 2024.
  • Anaptysbio, Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $8.19M, a 4.89% increase year-over-year.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $8.19M +$382K +4.89% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $7.54M -$883K -10.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $10.1M +$1.27M +14.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q3 2023 $7.81M +$1.54M +24.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $8.43M +$1.77M +26.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $8.86M +$1.12M +14.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $6.27M +$1.91M +43.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $6.66M +$2.97M +80.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $7.74M +$4.43M +134% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $4.36M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $3.69M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $3.32M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.